Glutaminase-IN-3（Cat No.:I045031）is a potent and selective inhibitor of glutaminase, the enzyme that converts glutamine to glutamate, a key step in cellular energy metabolism and biosynthesis. By targeting glutaminase, this compound disrupts glutamine-dependent metabolic pathways, making it a valuable tool in cancer research, particularly in studying tumors with glutamine addiction such as glioblastoma and pancreatic cancer. Glutaminase-IN-3 is often used in preclinical models to investigate metabolic vulnerabilities in cancer cells. Its specificity and effectiveness support its use in evaluating therapeutic strategies that exploit altered glutamine metabolism in disease contexts.